Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
REPROS THERAPEUTICS INC. (RPRX)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Gross profit | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Research and development | 27134.0% | 219236.4% | 301188.9% | 262855.6% | 470666.7% | 434100.0% | 689.8% | 4185.5% |
| General and administrative | 9717.0% | 46245.5% | 60411.1% | 53533.3% | 160900.0% | 190550.0% | 542.8% | 857.2% |
| Depreciation | 10.6% | 218.2% | 477.8% | 444.4% | 533.3% | 5750.0% | 20.7% | 13.1% |
| EBIT | -36851.1% | -265481.8% | -361600.0% | -316388.9% | -631566.7% | -624650.0% | -1232.5% | -5042.6% |
| Pre-tax income | -36751.1% | -265381.8% | -361500.0% | -316288.9% | -631466.7% | -624550.0% | -1132.5% | -4942.6% |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -36751.1% | -265381.8% | -361500.0% | -316288.9% | -631466.7% | -624550.0% | -1132.5% | -4942.6% |
|